• Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • Cetilar Oro
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
    • Akern
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Sustainability
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • SiderAL Med
      • Cetilar Crema
      • Cetilar Patch
      • Cetilar Tape
      • Cetilar Oro
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
    • Akern
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Sustainability
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • it
  • en

Presentations

  • 2022 FY FINANCIAL RESULTS
  • INVESTOR DAY FEBRUARY 2023
  • 2022 Q3 FINANCIAL RESULTS
  • 2022 H1 FINANCIAL RESULTS
  • ISMO CONFERENCE – PARIS
  • Q1 2022 FINANCIAL RESULTS
  • 2021 FY FINANCIAL RESULTS
  • 2021 Q3 FINANCIAL RESULTS
  • VIRTUAL STAR CONFERENCE – FALL EDITION 2021
  • 2021 H1 FINANCIAL RESULTS
  • 2020 FY FINANCIAL RESULTS FULL VERSION
  • 2020 FY ANALYSTS PRESENTATION

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info
info@pharmanutra.it
Commerciale
commerciale@pharmanutra.it
Investor relations
investorrelation@pharmanutra.it
Distribution
internationaldept@pharmanutra.it

Product sites

sideral.it

cetilar.it

ultramag.it

apportal.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter
Privacy & Cookie policy Change cookie preferences General conditions PRIVACY INFORMATION FOR CUSTOMERS

© 2023 2020 PharmaNutra SpA - All rights reserved

Modifica preferenze Cookie
Modifica preferenze Cookie